CompletedPhase 2

A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer

NCT04796623

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

The Fifth Medical Center of PLA General Hospital

Beijing, Beijing Municipality, China

+16 additional locations

Save this trial

The Fifth Medical Center of PLA General HospitalBeijing, Beijing Municipality, China
Chongqing University Cancer HospitalChongqing, Chongqing Municipality, China
Gansu Provincial HostipalLanzhou, Gansu, China
Guangdong General HospitalGuangzhou, Guangdong, China
Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, China
Guangxi Medical University Affiliated Tumor HospitalNanning, Guangxi, China
The Fourth Hospital of Hebei Medical UniversityShijiazhuang, Hebei, China
Harbin Medical University Affiliated Cancer HospitalHarbin, Heilongjiang, China
Hunan Cancer HospitalChangsha, Hunan, China
Jiangsu Province HospitalNanjing, Jiangsu, China
The Second Hospital of Dalian Medical UniversityDalian, Liaoning, China
Liaoning Cancer Hospital & InstituteShenyang, Liaoning, China
Shanghai East HospitalShanghai, Shanghai Municipality, China
The Second Affiliated Hospital of PLA Air Force Military Medical UniversityXi’an, Shanxi, China
The First Affiliated Hospital of Xi'an Jiao Tong UniversityXi’an, Shanxi, China
Affiliated Tumor Hospital of Xinjiang Medical UniversityÜrümqi, Xinjiang, China
The First Affiliated Hospital Zhejiang University School of MedicineHangzhou, Zhejiang, China